Telmisartan: from lowering blood pressure to end-organ protection

ISSN： 1479-6678

Source： Future Cardiology, Vol.1, Iss.1, 2005-01, pp. : 7-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Central Blood Pressure and End-organ Damage

Current Hypertension Reviews, Vol. 8, Iss. 2, 2012-05 ,pp. : 100-107

Bentham Science Publishers

Access to resources Recommend Favorite

Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit beyond Blood Pressure Lowering?

Cerebrovascular Diseases, Vol. 26, Iss. 5, 2008-10 ,pp. : 563-564

Karger

Access to resources Recommend Favorite

Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?

By Neldam Steen

Future Cardiology, Vol. 6, Iss. 1, 2010-01 ,pp. : 129-135

Future Medicine

Access to resources Recommend Favorite

Hypertension and Lowering Blood Pressure

Cerebrovascular Diseases, Vol. 15, Iss. 2, 2003-04 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Angiotensin Receptor Blockers and Target-Organ Protection Beyond Blood Pressure Control

By Riccardo Sarzani Paolo Dessì-Fulgheri Alessandro Rappelli

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 2, 2004-01 ,pp. : 65-73

Adis International

Access to resources Recommend Favorite